MBI-226 FDA Approval Status
FDA Approved: No
Brand name: MBI-226
Generic name: omiganan pentahydrochloride
Company: Micrologix Biotech Inc
Treatment for: Infection Prophylaxis
Development timeline for MBI-226
| Date | Article |
|---|---|
| Jan 21, 2004 | Micrologix Meets with FDA on MBI-226 |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.